Chesnara Crecimiento futuro
Future controles de criterios 1/6
Chesnara is forecast to grow earnings at 11.8% per annum. EPS is expected to grow by 11.7% per annum.
Información clave
11.8%
Tasa de crecimiento de los beneficios
11.7%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Insurance | 18.5% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | 11.5% |
| Cobertura de analistas | Low |
| Última actualización | 11 Sep 2024 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Chesnara's (LON:CSN) Dividend Will Be Increased To UK£0.15
Apr 03
We Think Shareholders May Want To Consider A Review Of Chesnara plc's (LON:CSN) CEO Compensation Package
May 12Is Chesnara plc (LON:CSN) A Strong Dividend Stock?
Mar 26What Type Of Shareholders Make Up Chesnara plc's (LON:CSN) Share Registry?
Mar 04If You Had Bought Chesnara's (LON:CSN) Shares Three Years Ago You Would Be Down 30%
Feb 12Chesnara plc (LON:CSN) On An Uptrend: Could Fundamentals Be Driving The Stock?
Jan 22
Are Dividend Investors Making A Mistake With Chesnara plc (LON:CSN)?
Dec 18What Kind Of Shareholders Own Chesnara plc (LON:CSN)?
Nov 30Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2024 | 410 | 5 | 38 | 38 | N/A |
| 3/31/2024 | 390 | 12 | 1 | 1 | N/A |
| 12/31/2023 | 370 | 19 | -36 | -35 | N/A |
| 9/30/2023 | 353 | 15 | -60 | -59 | N/A |
| 6/30/2023 | 338 | 13 | -49 | -46 | N/A |
| 3/31/2023 | 290 | -10 | -47 | -44 | N/A |
| 12/31/2022 | 241 | -34 | -45 | -42 | N/A |
| 9/30/2022 | 506 | -28 | -40 | -37 | N/A |
| 6/30/2022 | 771 | -22 | -35 | -31 | N/A |
| 3/31/2022 | 1,135 | 3 | -6 | -2 | N/A |
| 12/31/2021 | 1,500 | 27 | 23 | 27 | N/A |
| 9/30/2021 | 1,571 | 37 | -23 | -23 | N/A |
| 6/30/2021 | 1,641 | 46 | -68 | -73 | N/A |
| 3/31/2021 | 1,137 | 33 | -7 | -10 | N/A |
| 12/31/2020 | 633 | 21 | 54 | 52 | N/A |
| 9/30/2020 | 500 | 20 | 61 | 62 | N/A |
| 6/30/2020 | 366 | 18 | 67 | 72 | N/A |
| 3/31/2020 | 904 | 49 | 8 | 13 | N/A |
| 12/31/2019 | 1,442 | 79 | -50 | -47 | N/A |
| 9/30/2019 | 1,014 | 68 | -3 | -1 | N/A |
| 6/30/2019 | 586 | 57 | 44 | 46 | N/A |
| 3/31/2019 | 304 | 40 | 51 | 53 | N/A |
| 12/31/2018 | 23 | 24 | 59 | 61 | N/A |
| 9/30/2018 | 407 | 39 | 36 | 38 | N/A |
| 6/30/2018 | 791 | 53 | 14 | 15 | N/A |
| 3/31/2018 | 814 | 66 | N/A | 37 | N/A |
| 12/31/2017 | 837 | 78 | N/A | 60 | N/A |
| 9/30/2017 | 846 | 80 | N/A | 38 | N/A |
| 6/30/2017 | 854 | 82 | N/A | 16 | N/A |
| 3/31/2017 | 761 | 58 | N/A | -22 | N/A |
| 12/31/2016 | 667 | 35 | N/A | -60 | N/A |
| 9/30/2016 | 442 | 24 | N/A | -32 | N/A |
| 6/30/2016 | 217 | 12 | N/A | -5 | N/A |
| 3/31/2016 | 254 | 26 | N/A | -2 | N/A |
| 12/31/2015 | 292 | 40 | N/A | 2 | N/A |
| 9/30/2015 | 426 | 35 | N/A | 4 | N/A |
| 6/30/2015 | 561 | 31 | N/A | 7 | N/A |
| 3/31/2015 | 573 | 28 | N/A | 31 | N/A |
| 12/31/2014 | 586 | 26 | N/A | 56 | N/A |
| 9/30/2014 | 643 | 40 | N/A | 43 | N/A |
| 6/30/2014 | 700 | 55 | N/A | 31 | N/A |
| 3/31/2014 | 718 | 52 | N/A | -1 | N/A |
| 12/31/2013 | 736 | 49 | N/A | -33 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: CSN's forecast earnings growth (11.8% per year) is above the savings rate (1.9%).
Beneficios vs. Mercado: CSN's earnings (11.8% per year) are forecast to grow slower than the UK market (14.4% per year).
Beneficios de alto crecimiento: CSN's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: Insufficient data to determine if CSN's revenue is forecast to grow faster than the UK market.
Ingresos de alto crecimiento: Insufficient data to determine if CSN's revenue is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: CSN's Return on Equity is forecast to be low in 3 years time (11.5%).